1. Late Outcome of Spinal Cord Stimulation for Unreconstructable and Limb-threatening Lower Limb Ischemia.
- Author
-
Gersbach, P.A., Argitis, V., Gardaz, J.-P., von Segesser, L.K., and Haesler, E.
- Subjects
MEDICAL sciences ,VASCULAR surgery ,LIFE sciences ,BIOLOGY - Abstract
Objectives: To determine whether the initial benefits of spinal cord stimulation (SCS) treatment for critical limb ischemia (CLI) persist over years. Design: Analysis of data prospectively collected for every CLI patient receiving permanent SCS. Follow-up range 12 to 98 months (mean 46±23, median 50 months). Population: 87 patients (28% stage III, 72%stage IV) with unreconstructable CLI due (83%) or not (17%) to atherosclerosis and with an initial sitting/supine transcutaneous pO2 gradient >15mmHg. Methods: Assessment of actuarial patient survival (PS), limb salvage (LS) and amputation-free patient survival (AFPS). Analysis of the impact of 15 risk factors on long-term outcomes using the Fischer''s exact test for categorical variables and the t test for continuous variables. Results: Follow-up was complete for patient and limb survival. A single non-atherosclerotic patient died during follow-up. Among atherosclerotic patients PS decreased from 88% at 1y, to 76% at 3y, 64% at 5y and 57% at 7y. LS reached 84% at 1y, 78% at 2y, 75% at 3y and remained stable thereafter. Diabetes was found to affect LS (p <0.05) and heart disease to reduce PS (p <0.01). AFPS was reduced in heart patients (p <0.01), diabetics (p <0.05) and in patients with previous stroke (p <0.05). Conclusions: In CLI patients the beneficial effects of SCS persist far beyond the first year of treatment and major amputation becomes infrequent after the second year. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF